ARCHIVES

NTP Board Considers Modification Of Human Risk Statement, Adopts Plan For Chemical Selection

This article is from The Cancer Letter archive.

Vol. 06 No. 44 | November 7, 1980

Download PDF Visit The Full Archive

Related Articles

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

March 31, 2000

In Brief: John Young to Leave NCI for ELM; Yates Looking for Chief Of Outpatient Services At RPI

March 18, 1988

Ultrasound Shown to be Superior Diagnostic Compared to Mammography in Women Ages 30-39

October 26, 2012

NCI-Approved CTEP Trials For the Month of September

September 28, 2012

Greenwald Lists Items Missing Because Not Enough Money Available

November 25, 1988

Bush Appoints Lander To NCAB

January 24, 2003